MA

Muqtadeer Abdul Aziz Ansari

Active Director Director DIN 09189182
DIN 09189182 First appointment May 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Muqtadeer Abdul Aziz Ansari

Data last updated:

Muqtadeer Abdul Aziz Ansari is a Director at Mediaims Health Care Private Limited (since 2021). The company operates in Healthcare.

DIN 09189182
Primary Designation Director
Industry Healthcare
First Appointment 31 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mediaims Health Care Private Limited U85100MH2021PTC361312
Director31 May 20212021Active

Board colleagues of Muqtadeer Abdul Aziz Ansari

Directorship timeline

Open interactive timeline →
Mediaims Health Care Private Limited
Premium access

Shareholding and investment profile for Muqtadeer Abdul Aziz Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muqtadeer Abdul Aziz Ansari

Muqtadeer Abdul Aziz Ansari currently holds 1 directorship: Mediaims Health Care Private Limited (Director, since 31 May 2021).

Muqtadeer Abdul Aziz Ansari was first appointed on 31 May 2021 as Director at Mediaims Health Care Private Limited.

The current boards of Muqtadeer Abdul Aziz Ansari's companies include Ansari Ishtyaque Abdul Aziz (Mediaims Health Care Private Limited), Ashfaque Ansari (Mediaims Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available